Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome

被引:0
|
作者
Lingeng Lu
Chong Zhang
Gongjian Zhu
Melinda Irwin
Harvey Risch
Guido Menato
Marco Mitidieri
Dionyssios Katsaros
Herbert Yu
机构
[1] Yale University School of Medicine,Department of Epidemiology and Public Health, Yale Cancer Center
[2] Gansu Provincial Hospital for the Protection of Mother and Baby's Health,Gansu Provincial Academy of Medical Science
[3] Gansu Provincial Tumor Hospital,Department of Obstetrics and Gynecology, Gynecologic Oncology and Breast Cancer Unit
[4] University of Turin,undefined
来源
关键词
Breast Cancer; Endocrine Therapy; Telomere Length; Expression Index; Maintain Genome Stability;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Associations between telomere length, subclinical and clinical cardiovascular disease
    Fitzpatrick, AL
    Kronmal, RA
    Aviv, A
    Gardner, JP
    Psaty, BM
    Jenny, NS
    Tracy, RP
    CIRCULATION, 2005, 111 (14) : E221 - E221
  • [42] TELOMERE LENGTH, TELOMERASE ACTIVITY AND TELOMERE-BINDING PROTEINS IN BLADDER CANCER: RELATIONSHIP WITH GRADING AND RECURRENCE
    Mucciardi, Giuseppe
    Gali, Alessandro
    Mucciardi, Massimo
    Anastasi, Giuseppina
    Ciccarello, Giuseppe
    Inferrera, Antonino
    Macchione, Luciano
    Magno, Carlo
    ANTICANCER RESEARCH, 2011, 31 (05) : 1941 - 1942
  • [43] Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: Correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs
    Asai, A
    Kiyozuka, Y
    Yoshida, R
    Fujii, T
    Hioki, K
    Tsubura, A
    ANTICANCER RESEARCH, 1998, 18 (3A) : 1465 - 1472
  • [44] Telomerase activity and telomere length in the haemopoietic system: Changes with aging, disease, and therapy
    Robertson, JD
    Wynn, RF
    JOURNAL OF ANTI-AGING MEDICINE, 2000, 3 (04): : 389 - 395
  • [45] Evaluation of telomere length and telomerase activity on predicting in vitro fertilization treatment outcomes
    Fragkiadaki, Persefoni
    Kouvidi, Elisavet
    Angelaki, Anna
    Nikolopoulou, Dimitra
    Vakonaki, Elena
    Tsatsakis, Aristidis
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2024, 41 (06) : 1463 - 1473
  • [46] Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast
    Rha, SY
    Park, KH
    Kim, TS
    Yoo, NC
    Yang, WI
    Roh, JK
    Min, JS
    Lee, KS
    Kim, BS
    Choi, JH
    Lim, HY
    Chung, HC
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (04) : 839 - 845
  • [47] Current Progress in Targeting Telomere and Telomerase Enzymes for the Treatment of Cancer
    Garg, Aakriti
    Khan, Imran
    Nidhi
    Khan, Mohd. Ashif
    CURRENT CANCER THERAPY REVIEWS, 2024, 20 (01) : 26 - 39
  • [48] Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients
    Kroupa, Michal
    Rachakonda, Sivaramakrishna
    Vymetalkova, Veronika
    Tomasova, Kristyna
    Liska, Vaclav
    Vodenkova, Sona
    Cumova, Andrea
    Rossnerova, Andrea
    Vodickova, Ludmila
    Hemminki, Kari
    Soucek, Pavel
    Kumar, Rajiv
    Vodicka, Pavel
    MUTAGENESIS, 2020, 35 (06) : 491 - 497
  • [49] Telomere Length and Risk of Cardiovascular Disease and Cancer
    Said, M. Abdullah
    Eppinga, Ruben N.
    Hagemeijer, Yanick
    Verweij, Niek
    van der Harst, Pim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 506 - 507
  • [50] Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study
    Pellatt, Andrew J.
    Wolff, Roger K.
    Torres-Mejia, Gabriela
    John, Esther M.
    Herrick, Jennifer S.
    Lundgreen, Abbie
    Baumgartner, Kathy B.
    Giuliano, Anna R.
    Hines, Lisa M.
    Fejerman, Laura
    Cawthon, Richard
    Slattery, Martha L.
    GENES CHROMOSOMES & CANCER, 2013, 52 (07): : 595 - 609